← Open Payments lookup

FRANK FLOCA: Open Payments

NPI 1962443382 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,729 in 100 payments from 13 companies in 2025. Trend: 2023 $6,575 · 2024 $11,406 · 2025 $2,729

Food & beverage: $2,729
CompanyPaymentsAmount
Alkermes, Inc.20$646
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$574
Otsuka America Pharmaceutical, Inc.17$374
Teva Pharmaceuticals USA, Inc.17$287
Vanda Pharmaceuticals Inc.13$286
E.R. Squibb & Sons, L.L.C.6$210
Janssen Scientific Affairs, LLC1$120
Janssen Pharmaceuticals, Inc5$92
Supernus Pharmaceuticals, Inc.2$42
Alpha Cognition USA, Inc.1$36

Products named: CAPLYTA, ARISTADA, REXULTI, FANAPT, UZEDY, INVEGA SUSTENNA, COBENFY, LYBALVI.

Industry payments across TX — which companies pay providers there.